Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LORD

Showing results (431-440 of 511) with videos related to

Pageof 52
Sort By:
Cancer Discovery|March 15, 2015
Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast CancersJohnathan Watkins, Daniel Weekes, Vandna Shah, et al.
Cell Reports|May 17, 2018
The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient CellsMarco Barazas, Stefano Annunziato, Stephen J Pettitt, et al.
Nature Communications|August 1, 2025
Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trialMagnus T Dillon, Emmanuel C Patin, Kabir Mohammed, et al.
Cancers|August 7, 2021
Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell CarcinomaSaira Khalique, Sarah Nash, David Mansfield, et al.
Molecular Cancer Therapeutics|July 2, 2016
Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with DasatinibRowan E Miller, Rachel Brough, Ilirjana Bajrami, et al.
Molecular Cancer Therapeutics|November 15, 2017
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast CancerKalnisha Naidoo, Patty T Wai, Sarah L Maguire, et al.
Nature Communications|May 12, 2018
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistanceStephen J Pettitt, Dragomir B Krastev, Inger Brandsma, et al.
Nature|September 10, 2020
Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancerZhong Y Yeow, Bramwell G Lambrus, Rebecca Marlow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Tiling path genomic profiling of grade 3 invasive ductal breast cancersRachael Natrajan, Maryou B Lambros, Socorro María Rodríguez-Pinilla, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
A geothermal amoeba sets a new upper temperature limit for eukaryotesH Beryl Rappaport, Natalie A Petek-Seoane, Tomáš Tyml, et al.
Pageof 52

Showing results (431-440 of 511) with videos related to

Sort By:
Pageof 52
Cancer Discovery|March 15, 2015
Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast CancersJohnathan Watkins, Daniel Weekes, Vandna Shah, et al.
Cell Reports|May 17, 2018
The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient CellsMarco Barazas, Stefano Annunziato, Stephen J Pettitt, et al.
Nature Communications|August 1, 2025
Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trialMagnus T Dillon, Emmanuel C Patin, Kabir Mohammed, et al.
Cancers|August 7, 2021
Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell CarcinomaSaira Khalique, Sarah Nash, David Mansfield, et al.
Molecular Cancer Therapeutics|July 2, 2016
Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with DasatinibRowan E Miller, Rachel Brough, Ilirjana Bajrami, et al.
Molecular Cancer Therapeutics|November 15, 2017
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast CancerKalnisha Naidoo, Patty T Wai, Sarah L Maguire, et al.
Nature Communications|May 12, 2018
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistanceStephen J Pettitt, Dragomir B Krastev, Inger Brandsma, et al.
Nature|September 10, 2020
Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancerZhong Y Yeow, Bramwell G Lambrus, Rebecca Marlow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Tiling path genomic profiling of grade 3 invasive ductal breast cancersRachael Natrajan, Maryou B Lambros, Socorro María Rodríguez-Pinilla, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
A geothermal amoeba sets a new upper temperature limit for eukaryotesH Beryl Rappaport, Natalie A Petek-Seoane, Tomáš Tyml, et al.
Pageof 52